# Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk

> **NCT02482207** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 96 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Rosuvastatin
- **BEHAVIORAL:** Life style modification

## Key facts

- **NCT ID:** NCT02482207
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2019-11-26
- **Final completion:** 2019-11-26
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2021-01-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482207, "Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02482207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*